Integra LifeSciences Investor Relations Material
Latest events
Q1 2025
Integra LifeSciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Integra LifeSciences Holdings Corporation
Access all reports
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instrumentsfor use in neurosurgery, extremity reconstruction, and general surgery. It offers tissue ablation products that are used to treat soft tissue abnormalities, including peripheral nerve sheath tumors; uterine fibroids; adipose tissue removal; treating cancerous or non-cancerous prostate lesions; and percutaneous needle-based treatments for lung disease.
Key slides for Integra LifeSciences Holdings Corporation
Q1 2025
Integra LifeSciences Holdings Corporation
Q1 2025
Integra LifeSciences Holdings Corporation
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
IART
Country
🇺🇸 United States